Mobara, Japan

Shigemitsu Nagao


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Tokushima, JP (1988)
  • Mobara, JP (1990 - 1991)

Company Filing History:


Years Active: 1988-1991

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Shigemitsu Nagao: Innovator in Beta-Lactam Derivatives

Introduction

Shigemitsu Nagao is a notable inventor based in Mobara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the production of beta-lactam derivatives. With a total of 4 patents to his name, Nagao's work has had a lasting impact on medicinal chemistry.

Latest Patents

Nagao's latest patents include a method for the production of beta-lactam derivatives. This invention provides a method of producing a beta-lactam derivative represented by a specific formula. The method consists essentially of the step of reacting a beta-lactam derivative with a phenol in a defined reaction system. Another significant patent is for the production of 3-exomethylenecepham derivatives. This method involves reacting a cephem with lead metal while maintaining the pH of the reaction system within a specific range.

Career Highlights

Throughout his career, Shigemitsu Nagao has worked with prominent companies such as Otsuka Pharmaceutical Co., Ltd. and Otsuka Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Nagao has collaborated with notable individuals in the field, including Michio Sasaoka and Sigeru Torii. These collaborations have likely enriched his research and development efforts.

Conclusion

Shigemitsu Nagao's contributions to the field of pharmaceuticals, particularly in beta-lactam derivatives, highlight his innovative spirit and dedication to advancing medicinal chemistry. His patents and collaborations reflect a commitment to improving healthcare through scientific discovery.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…